Change in Orion Corporation’s holding of treasury shares

    NEXT STORY
    THE ELSAH PROJECT PUSHES THE LIMITS OF WEARABLES
    PREV STORY
    Global Home Infusion Therapy Market Anticipated to Reach $38.7 Billion by 2026
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Great Basin Scientific Submits 510(k) Application to the FDA for Stool Bacterial Pathogens Panel

    SALT LAKE CITY, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), ...

    author_avatar
    NASDAQ Market News

    FDA approves Roche’s Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer

    author_avatar
    NASDAQ Market News

    CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor Reception at the 32nd Annual Society for Immunotherapy of Cancer Meeting

    ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), ...

    author_avatar
    NASDAQ Market News